Table of Contents : Hepatitis B Annual : 2004 - 1(1)This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

This page shows you the latest items in this publication.

Pages: 1 2

58 records returned

Hepatitis B viral infection: Emerging issuesEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Shivaram Prasad Singh, Yogesh Kumar ChawlaHepatitis B Annual 2007 4(1):7-11
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - July 30, 2009 Category: Hematology Authors: Shivaram Prasad Singh, Yogesh Kumar Chawla Source Type: journals

Hepatitis B virus and pregnancyEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Silvia SookoianHepatitis B Annual 2007 4(1):12-23Hepatitis B virus (HBV) infection is very common, with over 350 million chronically infected people worldwide. This review plans to answer some key questions regarding hepatitis B infection during pregnancy, in order to provide healthcare professionals with updated information on the current knowledge in this field. The focus is on the following topics: the main risk factors associated with vertical transmission of HBV in pregnant women who are chronically infected, the influence of pregnancy on HBV viral load, and the effect of pregnancy on the clinical course of chronic he...
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - July 30, 2009 Category: Hematology Authors: Silvia Sookoian Source Type: journals

HBV drug resistance : Its relevance in clinical practiceEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Rajib Kishore Hazam, Premashis KarHepatitis B Annual 2007 4(1):24-39Drug resistance can be considered as a natural response to the selective pressure of the drug. An increase in HBV DNA can be a good indicator of the presence of a resistant HBV mutant population. The nucleoside analogues Lamivudine, Adefovir, Entecavir etc. are oral drugs used for Hepatitis B viral infection. Resistance to HBV drugs arises due to mutations in the polymerase gene. The HBV polymerase can be divided into 4 domains: 1) the terminal protein, 2) the variable spacer domain, 3) the polymerase/reverse transcriptase and 4) the RNase. Drug resistance...
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - July 30, 2009 Category: Hematology Authors: Rajib Kishore Hazam, Premashis Kar Source Type: journals

Hepatitis B virus serology: Use and interpretationEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
This article reviews the clinical use of serologic and nucleic acid tests as markers of disease activity.
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - July 30, 2009 Category: Hematology Authors: Sunil M Shah, Shivaram Prasad Singh Source Type: journals

Hepatitis B vaccine induced HBsAg positivityEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Shivaram Prasad SinghHepatitis B Annual 2007 4(1):55-60Hepatitis B vaccine can induce transient hepatitis B surface antigen positivity not only in adult hemodialysis patients but also in normal adults and children. Hence hepatitis B vaccinees may be mistaken for confirmed hepatitis B surface antigen-positive carrier. Hence blood donors should not donate blood in this early post-vaccination period and renal dialysis patients should not be screened for hepatitis B surface antigen for at least 21 to 28 days after hepatitis B vaccination. These guidelines could prevent individuals in the early post-inoculation period from bein...
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - July 30, 2009 Category: Hematology Authors: Shivaram Prasad Singh Source Type: journals

Non-invasive markers of hepatic fibrosis in chronic Hepatitis B: A reviewEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Mamun Al-Mahtab, Salimur Rahman, Mobin KhanHepatitis B Annual 2007 4(1):61-71Assessment of fibrosis is important in chronic hepatitis B for a number of reasons including decision-making regarding treatment and predicting prognosis.Currently liver biopsy is considered the gold standard for assessing liver histology. However, since liver biopsy has significant limitations,the quest for a non-invasive alternative to assess hepatic fibrosis continues. A review of published literature reveals that extensive research has been carried out in this field, and several simple to complicated alternatives to liver biopsy for assessing ...
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - July 30, 2009 Category: Hematology Authors: Mamun Al-Mahtab, Salimur Rahman, Mobin Khan Source Type: journals

Complementary and alternative therapies in the treatment of chronic hepatitis BEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Jia-Ming Chang, Kai-Ling HuangHepatitis B Annual 2007 4(1):72-106Hepatitis B virus (HBV) infects approximately more than 350 million people worldwide, especially in Asia, Africa, southern Europe and Latin America. Except for interferon-&#945;, most anti-HBV drugs are derived from the anti-herpes and anti-HIV drugs. Because of the high cost of hepatitis B medications, herbs-also called 'complementary and alternative therapies' in modern Western science-are widely used for treatment of chronic hepatitis B in developing countries. Herbals confer their activities not only by inhibiting HBV secretion bu...
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - July 30, 2009 Category: Hematology Authors: Jia-Ming Chang, Kai-Ling Huang Source Type: journals

Management of severe acute hepatitis BEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Sudeep Khanna, Rakesh TandonHepatitis B Annual 2007 4(1):107-117HBV infection is a major public health problem. Acute viral hepatitis B is successfully cleared in more than 95% of immunocompetent patients. HBV infection can cause severe acute hepatitis which can progress to acute liver failure. The purpose of this review is to discuss the immune response in acute hepatitis B and the possible role of HBV genotypes in development of severe acute HBV related hepatitis, define severe acute hepatitis B and to look at the role of the available antivirals in this clinical setting.
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - July 30, 2009 Category: Hematology Authors: Sudeep Khanna, Rakesh Tandon Source Type: journals

Management overview of chronic hepatitis B with established therapiesEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Deepak Narayan AmarapurkarHepatitis B Annual 2007 4(1):118-132Currently available options for the treatment of chronic hepatitis B virus (HBV) infection include standard and pegylated interferon alfa and Thymosin alpha, four oral antiviral agents (lamivudine, adefovir, entecavir, and telbivudine), two agents Tenofovir and emtricitabine approved in the HIV HBV co-infection are likely to be approved for HBV infection in immediate future. These treatment strategies are either therapies of finite duration that aim to achieve sustained off-therapy responses, or long-term treatments that aim to maintain on-therapy remission. Mos...
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - July 30, 2009 Category: Hematology Authors: Deepak Narayan Amarapurkar Source Type: journals

Hepatitis B: News from the research worldEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Paramasivan Piramanayagam, Gourdas ChoudhuriHepatitis B Annual 2007 4(1):133-145Hepatitis B is the leading cause of viral hepatitis in the developing world; about 400 million people are infected with chronic hepatitis B worldwide. Continuing research on hepatitis B over the last few decades has added considerably to our understanding of its replication, pathology, natural history, diagnosis and treatment. This section highlights a few selected landmark research articles published during the past year in the field of Hepatitis B. These articles enhance our understanding of the basic nature of this infection and help us to t...
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - July 30, 2009 Category: Hematology Authors: Paramasivan Piramanayagam, Gourdas Choudhuri Source Type: journals

Hepatitis B viral infection: Emerging issuesEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Singh Shivaram Prasad, Chawla Yogesh KumarHepatitis B Annual 2007 4(1):7-11
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - January 17, 2009 Category: Hematology Authors: Singh Shivaram Prasad, Chawla Yogesh Kumar Source Type: journals

Hepatitis B virus and pregnancyEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Sookoian SilviaHepatitis B Annual 2007 4(1):12-23Hepatitis B virus (HBV) infection is very common, with over 350 million chronically infected people worldwide. This review plans to answer some key questions regarding hepatitis B infection during pregnancy, in order to provide healthcare professionals with updated information on the current knowledge in this field. The focus is on the following topics: the main risk factors associated with vertical transmission of HBV in pregnant women who are chronically infected, the influence of pregnancy on HBV viral load, and the effect of pregnancy on the clinical course of chronic he...
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - January 17, 2009 Category: Hematology Authors: Sookoian Silvia Source Type: journals

HBV drug resistance : Its relevance in clinical practiceEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Hazam Rajib Kishore, Kar PremashisHepatitis B Annual 2007 4(1):24-39Drug resistance can be considered as a natural response to the selective pressure of the drug. An increase in HBV DNA can be a good indicator of the presence of a resistant HBV mutant population. The nucleoside analogues Lamivudine, Adefovir, Entecavir etc. are oral drugs used for Hepatitis B viral infection. Resistance to HBV drugs arises due to mutations in the polymerase gene. The HBV polymerase can be divided into 4 domains: 1) the terminal protein, 2) the variable spacer domain, 3) the polymerase/reverse transcriptase and 4) the RNase. Drug resistance...
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - January 17, 2009 Category: Hematology Authors: Hazam Rajib Kishore, Kar Premashis Source Type: journals

Hepatitis B virus serology: Use and interpretationEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
This article reviews the clinical use of serologic and nucleic acid tests as markers of disease activity.
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - January 17, 2009 Category: Hematology Authors: Shah Sunil M, Singh Shivaram Prasad Source Type: journals

Hepatitis B vaccine induced HBsAg positivityEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Singh Shivaram PrasadHepatitis B Annual 2007 4(1):55-60Hepatitis B vaccine can induce transient hepatitis B surface antigen positivity not only in adult hemodialysis patients but also in normal adults and children. Hence hepatitis B vaccinees may be mistaken for confirmed hepatitis B surface antigen-positive carrier. Hence blood donors should not donate blood in this early post-vaccination period and renal dialysis patients should not be screened for hepatitis B surface antigen for at least 21 to 28 days after hepatitis B vaccination. These guidelines could prevent individuals in the early post-inoculation period from bein...
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - January 17, 2009 Category: Hematology Authors: Singh Shivaram Prasad Source Type: journals

Non-invasive markers of hepatic fibrosis in chronic Hepatitis B: A reviewEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Al-Mahtab Mamun, Rahman Salimur, Khan MobinHepatitis B Annual 2007 4(1):61-71Assessment of fibrosis is important in chronic hepatitis B for a number of reasons including decision-making regarding treatment and predicting prognosis.Currently liver biopsy is considered the gold standard for assessing liver histology. However, since liver biopsy has significant limitations,the quest for a non-invasive alternative to assess hepatic fibrosis continues. A review of published literature reveals that extensive research has been carried out in this field, and several simple to complicated alternatives to liver biopsy for assessing ...
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - January 17, 2009 Category: Hematology Authors: Al-Mahtab Mamun, Rahman Salimur, Khan Mobin Source Type: journals

Complementary and alternative therapies in the treatment of chronic hepatitis BEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Chang Jia-Ming, Huang Kai-LingHepatitis B Annual 2007 4(1):72-106Hepatitis B virus (HBV) infects approximately more than 350 million people worldwide, especially in Asia, Africa, southern Europe and Latin America. Except for interferon-&#945;, most anti-HBV drugs are derived from the anti-herpes and anti-HIV drugs. Because of the high cost of hepatitis B medications, herbs-also called 'complementary and alternative therapies' in modern Western science-are widely used for treatment of chronic hepatitis B in developing countries. Herbals confer their activities not only by inhibiting HBV secretion bu...
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - January 17, 2009 Category: Hematology Authors: Chang Jia-Ming, Huang Kai-Ling Source Type: journals

Management of severe acute hepatitis BEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Khanna Sudeep, Tandon RakeshHepatitis B Annual 2007 4(1):107-117HBV infection is a major public health problem. Acute viral hepatitis B is successfully cleared in more than 95% of immunocompetent patients. HBV infection can cause severe acute hepatitis which can progress to acute liver failure. The purpose of this review is to discuss the immune response in acute hepatitis B and the possible role of HBV genotypes in development of severe acute HBV related hepatitis, define severe acute hepatitis B and to look at the role of the available antivirals in this clinical setting.
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - January 17, 2009 Category: Hematology Authors: Khanna Sudeep, Tandon Rakesh Source Type: journals

Management overview of chronic hepatitis B with established therapiesEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Amarapurkar Deepak NarayanHepatitis B Annual 2007 4(1):118-132Currently available options for the treatment of chronic hepatitis B virus (HBV) infection include standard and pegylated interferon alfa and Thymosin alpha, four oral antiviral agents (lamivudine, adefovir, entecavir, and telbivudine), two agents Tenofovir and emtricitabine approved in the HIV HBV co-infection are likely to be approved for HBV infection in immediate future. These treatment strategies are either therapies of finite duration that aim to achieve sustained off-therapy responses, or long-term treatments that aim to maintain on-therapy remission. Mos...
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - January 17, 2009 Category: Hematology Authors: Amarapurkar Deepak Narayan Source Type: journals

Hepatitis B: News from the research worldEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Piramanayagam Paramasivan, Choudhuri GourdasHepatitis B Annual 2007 4(1):133-145Hepatitis B is the leading cause of viral hepatitis in the developing world; about 400 million people are infected with chronic hepatitis B worldwide. Continuing research on hepatitis B over the last few decades has added considerably to our understanding of its replication, pathology, natural history, diagnosis and treatment. This section highlights a few selected landmark research articles published during the past year in the field of Hepatitis B. These articles enhance our understanding of the basic nature of this infection and help us to t...
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - January 17, 2009 Category: Hematology Authors: Piramanayagam Paramasivan, Choudhuri Gourdas Source Type: journals

Treatment of chronic hepatitis B: A bridge too farEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Singh Shivaram Prasad, Chawla Yogesh KumarHepatitis B Annual 2006 3(1):7-10
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - June 16, 2007 Category: Hematology Authors: Singh Shivaram Prasad, Chawla Yogesh Kumar Source Type: journals

Hepatitis B Eradication Day: It's never too late!!Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Singh Shivaram PrasadHepatitis B Annual 2006 3(1):11-13
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - June 16, 2007 Category: Hematology Authors: Singh Shivaram Prasad Source Type: journals

Telbivudine : A new treatment option in the management of chronic hepatitis BEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Fung James, Lai Ching-Lung, Yuen Man-FungHepatitis B Annual 2006 3(1):14-34
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - June 16, 2007 Category: Hematology Authors: Fung James, Lai Ching-Lung, Yuen Man-Fung Source Type: journals

Entecavir : A reviewEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Tan Chee-KiatHepatitis B Annual 2006 3(1):35-53
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - June 16, 2007 Category: Hematology Authors: Tan Chee-Kiat Source Type: journals

Hepatitis B virus genotypes: Epidemiology and therapeutic implicationsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Liu Chun-Jen, Kao Jia-HorngHepatitis B Annual 2006 3(1):54-75
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - June 16, 2007 Category: Hematology Authors: Liu Chun-Jen, Kao Jia-Horng Source Type: journals

Management of chronic hepatitis B infection in patients with end-stage renal disease and dialysisEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Wong Ping-Nam, Mak Siu-Ka, Wong Andrew Kui-ManHepatitis B Annual 2006 3(1):76-105
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - June 16, 2007 Category: Hematology Authors: Wong Ping-Nam, Mak Siu-Ka, Wong Andrew Kui-Man Source Type: journals

Management of chronic hepatitis B in childrenEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Liberek Anna, Luczak Graeyna, Gora-Gebka Magdalena, Landowski PiotrHepatitis B Annual 2006 3(1):106-127
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - June 16, 2007 Category: Hematology Authors: Liberek Anna, Luczak Graeyna, Gora-Gebka Magdalena, Landowski Piotr Source Type: journals

Extrahepatic manifestations of chronic hepatitis BEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Shim Michael, Han Steven-Huy BHepatitis B Annual 2006 3(1):128-154
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - June 16, 2007 Category: Hematology Authors: Shim Michael, Han Steven-Huy B Source Type: journals

Management of hepatitis B viral infection with normal ALTEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Amarapurkar DeepakHepatitis B Annual 2006 3(1):155-164
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - June 16, 2007 Category: Hematology Authors: Amarapurkar Deepak Source Type: journals

Controversies in the management of hepatitis BEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Choudhuri Gourdas, Piramanayagam PHepatitis B Annual 2006 3(1):165-179
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - June 16, 2007 Category: Hematology Authors: Choudhuri Gourdas, Piramanayagam P Source Type: journals

ForewordEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Acharya Subrat KumarHepatitis B Annual 2005 2(1):7-8
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - February 5, 2007 Category: Hematology Authors: Acharya Subrat Kumar Source Type: journals

Hepatitis B viral infection: Emerging challengesEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Chawla YKHepatitis B Annual 2005 2(1):9-10
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - February 5, 2007 Category: Hematology Authors: Chawla YK Source Type: journals

Management of chronic hepatitis B infection: Miles to go.......Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Singh Shivaram PrasadHepatitis B Annual 2005 2(1):11-13
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - February 5, 2007 Category: Hematology Authors: Singh Shivaram Prasad Source Type: journals

Occult hepatitis B virus infectionEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Allain Jean-PierreHepatitis B Annual 2005 2(1):14-30
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - February 5, 2007 Category: Hematology Authors: Allain Jean-Pierre Source Type: journals

Preventive and therapeutic approaches against hepatitis B virus by vaccineEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
This article reviews the development of more potent prophylactic vaccines against HBV and better regimens of therapeutic vaccines for patients with chronic hepatitis B with special reference to the recent developments in the relevant fields.
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - February 5, 2007 Category: Hematology Authors: Akbar Sk. Md. Fazle, Onji Morikazu Source Type: journals

Hepatitis B immunization: Is a booster necessary?Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Lu Chun-Yi, Chang Mei-HweiHepatitis B Annual 2005 2(1):56-73
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - February 5, 2007 Category: Hematology Authors: Lu Chun-Yi, Chang Mei-Hwei Source Type: journals

HBV variants: Clinical significance and public health implicationsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Revill Peter, Locarnini StephenHepatitis B Annual 2005 2(1):74-92Inadequate and/or inappropriate host immune responses, are mainly responsible for the liver disease of chronic hepatitis B. Infection of the hepatocyte with the hepatitis B virus (HBV) results in very high levels of viral replication without actually killing the infected cell directly. The HBV uses reverse transcription to copy its DNA genome and because of a lack of proof-reading capability, mutant viral genomes or quasi species, emerge continually. All the selection pressures, both endogenous (host immune clearance) and exogenous (vaccines and antiviral dru...
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - February 5, 2007 Category: Hematology Authors: Revill Peter, Locarnini Stephen Source Type: journals

Comparison of lamividine and adefovir dipivoxil in the treatment of chronic hepatitis BEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Leung NancyHepatitis B Annual 2005 2(1):93-126Nucleot(s)ide analogues are making milestones in the treatment of chronic hepatitis B (CHB). Lamivudine was approved by FDA for the treatment of chronic hepatitis B in adult patients n 1998 (ZeffixTM HeptodinTM HeptovirTM Epivir-HBVTM Glaxo Wellcome). Adefovir dipivoxil was approved by FDA in 2002 (Hepsera, Gilead). Both were licensed and available in many countries. A comparis...
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - February 5, 2007 Category: Hematology Authors: Leung Nancy Source Type: journals

Long-term management of patients with chronic hepatitis B virus infectionEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Lok Anna SFHepatitis B Annual 2005 2(1):127-153
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - February 5, 2007 Category: Hematology Authors: Lok Anna SF Source Type: journals

Pathogenesis, prevention and treatment of hepatitis B associated hepatocellular carcinomaEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
London W Thomas, Mason William S, Nguyen MinhhuyenHepatitis B Annual 2005 2(1):154-185
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - February 5, 2007 Category: Hematology Authors: London W Thomas, Mason William S, Nguyen Minhhuyen Source Type: journals

The epidemiology of hepatitis B virus infection in healthcare workers in the West and AsiaEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Alter Miriam JHepatitis B Annual 2005 2(1):186-192
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - February 5, 2007 Category: Hematology Authors: Alter Miriam J Source Type: journals

ForewordEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Blumberg Baruch SHepatitis B Annual 2004 1(1):5-6
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - October 20, 2006 Category: Hematology Authors: Blumberg Baruch S Source Type: journals

EditorialEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Singh Shivaram Prasad, Chawla Yogesh KumarHepatitis B Annual 2004 1(1):7-9
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - October 20, 2006 Category: Hematology Authors: Singh Shivaram Prasad, Chawla Yogesh Kumar Source Type: journals

From Australia antigen to eradication programsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Blumberg Baruch SHepatitis B Annual 2004 1(1):10-16
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - October 20, 2006 Category: Hematology Authors: Blumberg Baruch S Source Type: journals

Epidemiology of hepatitis B virus infection in IndiaEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Chowdhury AbhijitHepatitis B Annual 2004 1(1):17-24
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - October 20, 2006 Category: Hematology Authors: Chowdhury Abhijit Source Type: journals

Prophylaxis of viral hepatitis: A global perspectiveEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Chongsrisawat Voranush, Chatchatee Pantipa, Poovorawan YongHepatitis B Annual 2004 1(1):25-59
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - October 20, 2006 Category: Hematology Authors: Chongsrisawat Voranush, Chatchatee Pantipa, Poovorawan Yong Source Type: journals

Universal neonatal hepatitis B virus vaccination in India: Why?Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Aggarwal RakeshHepatitis B Annual 2004 1(1):60-71
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - October 20, 2006 Category: Hematology Authors: Aggarwal Rakesh Source Type: journals

Hepatitis B virus infection in children in IndiaEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Sathiyasekaran Malathi, Sankaranarayanan VSHepatitis B Annual 2004 1(1):72-91
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - October 20, 2006 Category: Hematology Authors: Sathiyasekaran Malathi, Sankaranarayanan VS Source Type: journals

Histopathological scoring of chronic viral hepatitisEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Gupta S DattaHepatitis B Annual 2004 1(1):92-112
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - October 20, 2006 Category: Hematology Authors: Gupta S Datta Source Type: journals

Management of chronic hepatitis due to hepatitis B virus infectionEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Acharya Subrat Kumar, Batra YogeshHepatitis B Annual 2004 1(1):113-139
Source: Table of Contents : Hepatitis B Annual : 2004 - 1(1) - October 20, 2006 Category: Hematology Authors: Acharya Subrat Kumar, Batra Yogesh Source Type: journals

Pages: 1 2